SSX3 antibody
Principal name
SSX3 antibody
Alternative names for SSX3 antibody
Synovial sarcoma X breakpoint 3, CT5.3, Cancer/testis antigen 5.3
SwissProt ID
Q99909 (Human)
Gene ID
10214 (SSX3)
Ncbi ID
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection))
Background of SSX3 antibody
- Kit Component:
- - KN203244G1, SSX3 gRNA vector 1 in pCas-Guide vector
- KN203244G2, SSX3 gRNA vector 2 in pCas-Guide vector
- KN203244D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Western Blot analysis of SSX3 expression in transfected 293T cell line (H00010214-T01) by SSX3 MaxPab polyclonal antibody.Lane 1: SSX3 transfected lysate(20.68 KDa).Lane 2: Non-transfected lysate.
Western Blot analysis of SSX3 expression in transfected 293T cell line (H00010214-T01) by SSX3 MaxPab polyclonal antibody.Lane 1: SSX3 transfected lysate(20.68 KDa).Lane 2: Non-transfected lysate.
Western Blot analysis of SSX3 expression in transfected 293T cell line by SSX3 monoclonal antibody (M03), clone 4A11.Lane 1: SSX3 transfected lysate(21.697 KDa).Lane 2: Non-transfected lysate.
WB Suggested Anti-SSX3 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1: 1562500; Positive Control: Jurkat cell lysate
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP324933 | SSX3 (transcript variant 1) |
||||
| Recombinant protein of human synovial sarcoma, X breakpoint 3 (SSX3), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY412140 | SSX3 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |